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Abstract
Pancreaticoduodenectomy (PD) will result in removal 
of important multiorgans in upper intestinal tract and 
subsequently secondary physiologic change. In the 
past, surgeons just focused on the safety of surgical 
procedure; however, PD is regarded as safe and widely 
applied to treatment of periampullary lesions. Practical 
issues after PD, such as, effect of duodenectomy, 
metabolic surgery-like effect, alignment effect of 
gastrointestinal continuity, and non-alcoholic fatty liver 
disease were summarized and discussed.
Key words: Pancreaticoduodenectomy; Delayed gastric 
emptying; Metabolic surgery; Exocrine insufficiency; 
Fatty liver; Postoperative pancreatic fistula
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Core tip: In the past, pancreaticoduodenectomy (PD) 
should be avoided because of its extremely high 
morbidity and mortality. With the advance of surgical 
techniques and perioperative management, PD has 
been regarded as good choice for the treatment of 
periampullary pathologic conditions. In this moment, 
turning our interest to potential physiological change 
following PD may be necessary, because PD always 
results in removal of important internal organs in 
upper gastrointestinal tract and altering normal path of 
gastrointestinal flow. Well awareness of these “internal” 
changes will be helpful for proper management of the 
patients with PD.
Kang CM, Lee JH.  Pathophysiology af ter  pancrea -
ticoduodenectomy. World J Gastroenterol 2015; 21(19): 
5794-5804  Available from: URL: http://www.wjgnet.
com/1007-9327/full/v21/i19/5794.htm  DOI: http://dx.doi.
org/10.3748/wjg.v21.i19.5794
INTRODUCTION
In the past, it was thought that pancrea­
ticoduodenectomy (PD) should be avoided because 
of its extremely high rates of morbidity (greater 
than 70%) and mortality (greater than 30%)[1]. 
More recently, many surgeons have focused on 
technical innovation to reduce postoperative severe 
morbidity after PD. Based on advancements in 
surgical experiences, perioperative management 
and interventional radiology, it is thought that most 
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Table 1  Experimental study showing the relationship between motilin and duodenectomy
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complications related to PD can be managed in a 
conservative way. Based on the literature, mortality 
after PD is now considered to be 2%­5% and morbidity 
is reported to be 33%­64%[2­4]. PD recently has gained 
wide acceptance as a safe surgical method of choice for 
the treatment of periampullary pathological conditions.
PD consists of two surgical components: (1) 
resection phase: removal of pancreatic head, common 
bile duct, gallbladder, and duodenum along with some 
part of the proximal jejunum. Partial gastrectomy 
can be included; and (2) reconstruction phase: 
gastrointestinal continuity is created by pancreatico­
enterostomy [pancreaticogastrostomy (PG) or 
pancreaticojejunostomy (PJ)], hepaticojejunostomy, 
and duodeno­or, gastro­jejunostomy.
When surgical technique is largely standardized, 
potential physiological changes following PD need to 
be concerned because PD results in the removal of 
important internal organs in the upper gastrointestinal 
tract and alters the normal path of the gastrointestinal 
flow. Therefore, surgeons who perform PD should be 
well aware of these “internal” challenges for proper 
management of patients with PD. Herein, the following 
issues will be discussed to understand the practical 
pathophysiological changes that occur after PD.
EFFECTS OF DUODENECTOMY
The duodenum is a source of various peptide 
hormones. Among them, motilin is a 22 amino acids 
peptide that is primarily localized in enterochromaffin 
cells of the duodenum and proximal jejunum[5], 
which is known to be responsible for phase Ⅲ activity 
of the gastroduodenal migrating motor complex 
(MMC)[5]. It was found that exogenous motilin could 
induce premature phase Ⅲ contraction in the upper 
gastrointestinal tract. Moreover, reduced plasma 
concentrations of motilin were associated with 
gastroparesis (Table 1). Therefore, PD can lead to the 
inevitable removal of the duodenum, which can reduce 
plasma levels of motilin, resulting in delayed gastric 
emptying (gastroparesis) by reducing coordinated 
stomach, duodenum and proximal jejunum movements.
Motilin is not yet available for clinical use. However, 
there is some clinical evidence to support these 
experiments and hypotheses. Naritomi et al[6] evaluated 
the first occurrence of MMC and motilin in patients with 
pylorus­preserving pancreaticoduodenectomy (PPPD) 
and duodenum­preserving pancreatic head resection 
(DPPHR). They found that the PPPD group required 
a longer amount of time for initial gastric phase Ⅲ 
Ref. Year Study design and model Primary end point Observations
Tanaka et al[74] 1987 Normal dog vs
Duodenectomized dog
Phase Ⅲ contraction,
plasma level of motilin
All control dogs showed characteristic MMC
Duodenectomized dog showed non-typical, irregular and non-cyclic 
pattern of contraction
Duodenectomized dog showed low plasma concentration of motilin 
without cyclical variation
Tanaka et al[75] 1988 Normal dog vs
Duodenectomized dog
Inter-digestive gastric and 
small intestinal MMC
plasma level of motilin 
and
Polypeptide Y
MMC was abolished in duodenectomized dogs (3 out of 4 dogs)
The other dogs showed intermittent cyclic, but markedly abnormal 
characteristics of gastric contraction
Jejunal MMC appeared with short interval
Duodenectomy abolished cyclic variation of plasma motilin and 
polypeptide Y
Suzuki et al[76] 2001 Conscious dog vs 
Duodenectomized dog
Phase Ⅲ contraction, 
plasma level of insulin, 
and motilin 
Duodenectomy resulted in no phase Ⅲ contraction in upper GI tract
Duodenectomy resulted in no fluctuation of plasma motilin (low level 
of motilin)
Exogenous administration of motilin resulted in comparable response 
of phased Ⅲ as shown in control
Malfertheiner et al[77] 1989  Normal dog vs Pancreatic trypsin In duodenectomized dog
Duodenectomized dog GI motility 
plasma motilin, PPY
   Trypsin secretion was not coordinated with inter-digestive motility, 
   motilin, and PPY
   Inter-digestive motility was altered
   Plasma level of motilin and PPY were reduced, and showed no cyclic 
   pattern
Itoh et al[78] 1976 Normal dog GI motility
plasma motilin
Gastrointestinal contractile activity in the conscious dog,
   Digestive states: motilin had no influence upon the motor activity
   Inter-digestive states: had influence upon the motor activity
Vantrappen et al[79] 1979 Human GI motility
plasma motilin level
The effect of exogenous motilin on interdigestive migrating motor 
complex
   Plasma motilin levels is one of the factor involved in the production 
   of the activity front of the MMC in man
Sarna et al[80] 1983 Normal dog Plasma motilin levels
Migrating myoelectric 
complexes (MMCs)
Cause and effect relationship between plasma motilin levels and 
migrating myoelectric complexes
   Endogenous motilin does not initiate spontaneous mmcs
   MMC contractions release motilin
GI: Gastrointestinal.
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recovery, and the plasma levels of motilin were lower. 
Yeo et al[7] performed a prospective randomized 
placebo­controlled trial and found that erythromycin 
could significantly accelerate gastric emptying after PD 
and reduce the incidence of delayed gastric emptying 
(DGE) by 37%. Indeed, erythromycin can act as 
a motilin agonist by binding motilin receptors, and 
its clinical benefit to improve gastric emptying has 
been demonstrated in diabetic gastroparesis[8] and 
postvagotomy gastroparesis[9]. Matsunaga et al[10] also 
showed manometric evidence of improved early gastric 
stasis by erythromycin after PPPD. Administration of 
saline caused no changes in gastric or jejunal motility; 
however, erythromycin could induce phase Ⅲ­like 
gastric contraction and reduce the amount of gastric 
juice output in all patients.
Duodenectomy also influences on the secretion of 
other gastrointestinal hormones. Malfertheiner et al[11] 
showed that plasma levels of pancreatic polypeptide (PP) 
were altered with no cyclic pattern in duodenectomized 
dogs. Müller et al[12] evaluated changes in CCK, PP, 
and gastrin in PPPD and DPPHR patients. They found 
that PP was significantly reduced in both PPPD and 
DPPHR, and cholecystokinin (CCK) was reduced in an 
early postoperative period after PPPD. Tangoku et al[13], 
and Kingsnorth et al[14] evaluated plasma gastrin and 
CCK responses between standard PD and PPPD. Basal 
plasma levels of gastrin and CCK were significantly 
higher in controls compared with patients with standard 
PD (p < 0.05), suggesting that preservation of the 
stomach and part of the duodenum (pylorus­preserving) 
appeared to be a more physiological procedure for 
performing PD.
Regarding reduced gastrin levels following PD, it 
has been proposed that postoperative atrophic changes 
in the remnant pancreas after PD can be derived from 
removal of the duodenum and distal stomach because 
these organs are a source of gastric stimulation[15]. 
Jang et al[16] investigated the effects of induced 
hypergastrinemia on the prevention of pancreatic 
atrophy after PPPD. They performed a randomized 
control study and successfully demonstrated that 
induced hypergastrinemia by Lansoprazole could 
prevent postoperative volume change of the remnant 
pancreas and preserve long­term exocrine and 
endocrine function in patients with PPPD. This study is 
a good example to show how potential physiological 
changes can be translated into clinical practice for 
proper management of patients who undergo PD.
Furthermore, Chung et al[17] investigated the role of 
vagal and efferent adrenergic innervation to coordinate 
the gastric and small intestinal MMCs after removing 
the pylorus, duodenum, and upper jejunum in three 
dogs. They concluded that duodenectomy could 
reestablish gastric MMC­like activity without motilin, 
showing a peak after 1­4 mo, and it appeared to require 
extrinsic innervation. PD sometimes (depending on the 
surgeons’ preference and disease extent) requires 
extensive soft tissue dissection around a major arterial 
system, including the celiac axis, common hepatic 
artery, and superior mesenteric artery for margin­
negative resection. Too much dissection of soft tissue 
(for example, extended PD) can result in surgical 
denervation of visceral autonomic nerves and can 
be one of the reasons for transient delayed gastric 
emptying in a clinical setting[18,19].
Based on this brief review of the literature, it can 
be noted that duodenectomy not only disrupts the 
coordination of gastric and intestinal MMC but also 
disrupts the coordination between inter­digestive 
motility and pancreatic secretion and abolishes the 
inter­digestive cyclic variations in plasma gastroin­
testinal hormones, such as motilin, CCK, gastrin, and 
pancreatic polypeptide (PP). Additionally, extensive 
soft tissue dissection­induced disconnection of neural 
stimulation and secondary postoperative inflammatory 
insults can cause pathophysiological changes after 
PD, which can be attributed to a clinical delay in 
postoperative recovery.
METABOLIC SURGERY-LIKE EFFECTS
The bariatric surgical procedures were attempted 
to promote weight loss by restricting food intake 
and promoting malabsorption. The most commonly 
performed procedures were Roux­en­Y gastric bypass 
(46.6%), vertical sleeve gastrectomy (27.8%), 
adjustable gastric banding (17.8%), and biliopancreatic 
diversion with duodenal switch (2.2%)[20]. Interestingly, 
when looking at schematic figures showing PD, it could 
be noted that PD is somewhat similar in appearance to 
Roux-en-Y gastric bypass (Figure 1). The food passage 
after PD could be similar to that after Roux­en­Y gastric 
bypass, bypassing duodenum and passing directly into 
distal jejunum. Natural bile and pancreatic flow can 
be thought of as a Roux-en-Y loop in PD. Therefore, 
PD might cause the physiological changes that appear 
after bariatric surgery.
Notably, glucagon­like peptide­1 (GLP­1) is an 
interesting gastrointestinal hormone. After Roux­en­Y 
gastric bypass, GLP­1 is secreted by L cells of the small 
bowel, with higher concentrations in the distal ileum 
and colon. This peptide is produced in response to a 
meal and decreases food intake through its effects on 
the hypothalamus and brainstem. Additionally, GLP­1 
is known to slow gastric emptying, inhibit glucagon 
release and stimulate the pancreas to secrete insulin 
(incretin effect)[21,22]. Recently, You et al[23] showed that 
about 30% of patients with PD were found to have 
hypertrophic changes in the remnant pancreas, and 
Wu et al[24] also reported resolution of diabetes after 
PD. They observed resolution of long-standing diabetes 
after PD in patients with (3, 9.1% of 33 patients, p = 
0.005) and without (6, 9.8% of 61 patients) pancreatic 
cancer, suggesting that PD­associated anatomical 
changes might play an important role in the resolution 
of DM after PD.
Despite conflicting observations about GLP-1 levels 
Kang CM et al . Pathophysiologic changes after PD
5797 May 21, 2015|Volume 21|Issue 19|WJG|www.wjgnet.com
after PD[25], several studies have investigated changes 
in plasma GLP­1 levels after PD. Ohtsuka et al[26] 
previously showed that improved glucose metabolism 
after PD was mainly influenced by improved insulin 
resistance. They observed significantly increased 
plasma GLP­1 levels after PD; however, even after 
removal of the pancreatic head (reduced pancreatic 
volume), β­cell function did not change. Muscogiuri 
et al[27] evaluated the effect of duodenectomy on 
GLP-1 secretion after PD. They found that PPPD 
was associated with a remarkable increase in GLP­1 
levels, which reached levels comparable with those 
observed after gastric bypass[28]. Harmuth et al[29] 
reported that conventional PD was associated with 
accelerated gastric emptying, enhanced postprandial 
GLP-1 release, and improved insulin sensitivity. The 
rapid transport of unabsorbed nutrients to the distal 
bowel triggers enhanced release of GLP­1, resulting in 
improved glycemic control.
Notably, GLP­1 agents used to control diabetes 
have been associated with an increased risk of 
pancreatic cancer in patients with type 2 diabetes[30]. 
However, a recent study demonstrated that GLP­1 
could harbor anticancer properties against pancreatic 
cancer. GLP­1 receptor activation has anti­tumor 
effects on human pancreatic cancers via inhibition 
of the PI3K/Akt pathway[31]. Additionally, activation 
of the GLP­1 receptor was found to inhibit growth 
and promote apoptosis of human pancreatic cancer 
cells[32]. PD­induced GLP­1 release can be used for 
future treatment of resected pancreatic head cancer, 
although further investigations are warranted.
ALIGNMENT EFFECT OF GI CONTINUITY
In addition to the direct effects of removing organ 
by resection, pathophysiological changes after PD 
will also be influenced by how the gastrointestinal 
alignment is rearranged in the reconstructive phase. 
Various methods for reconstruction, similar to 
gastrointestinal alignment, have been reported in PD, 
such as Billroth Ⅰ (the Imanaga method)[33], Billroth 
Ⅱ (the Whipple and/or Child method)[34], Roux­en­Y 
loop fashion[35], an additional Braun anastomosis[36], 
and retrocolic/antecolic reconstruction[37]. In 
clinical practice, DGE appears to represent the 
pathophysiological changes that occur after PD. 
Conflicting observations have been reported about 
the incidence of DGE, and the exact mechanisms to 
explain the occurrence of DGE according to different 
reconstruction method remain to be determined. 
However, robust evidence is accumulating about the 
incidence of DGE according to different gastrointestinal 
reconstructive methods following PD (Table 2).
Short­term perioperative outcomes, such as 
postoperative complications, length of hospital 
stay, and resuming of acceptable diet, are the main 
concerns after PD. Miyakawa et al[38] demonstrated 
that fat absorption after Billroth Ⅰ PG (PG­Ⅰ) is 
superior to that after Billroth Ⅱ PJ (PJ­Ⅱ) in patients 
with disordered exocrine function of the pancreatic 
remnant, suggesting that PG­I allows for more 
effective utilization of the exocrine enzymes of the 
pancreatic remnant because of elimination of the 
blind loop characteristic of the PJ­Ⅱ. Ohtsuka et al[39] 
evaluated nutritional status and quality of life after 
PD, and compared these data between 18 patients 
with end­to­end (Imanaga) and 13 patients with end­
to-side (Traverso) gastrointestinal reconstruction. 
They found that the scores of psychosocial conditions 
remained low, even over a long­term, in both groups. 
However, the values of nutritional parameters showed 
no significant difference between the two groups at 
each time point, suggesting that the postoperative 
quality of life and nutritional status were not different 
between Imanaga and Traverso reconstructions after 
PPPD. However, a paucity of high­level evidence 
exists about long­term outcomes, including nutritional 
outcomes and quality of patients’ life, which could be 
influenced by potential pathophysiological changes 
after PD according to reconstruction methods.
Some recent trials showed that removal of the 
pylorus could result in a lower incidence of DGE. 
Matsumoto et al[40] performed a prospective randomized 
comparison between PPPD and modified classical PD, 
and assessed the effects stomach­preserving PD on 
Figure 1  Schematic diagrams of pancreaticoduodenectomy and Roux-en-Y gastric bypass.
A B
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Table 2  Incidence of delayed gastric emptying according to different gastrointestinal reconstructive methods following 
pancreaticoduodenectomy
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postoperative DGE occurrence and long­term nutritional 
status. They observed that the incidence of DGE, as 
assessed by the International Study Group of Pancreatic 
Surgery, was similar (20% vs 12%, p = 0.414), and 
long­term nutritional status indicated by serum 
albumin levels, serum total cholesterol levels, and 
body mass index during the 3­year follow­up) were 
also comparable between the two groups. Similarly, 
Kawai et al[41] reported their prospective, randomized, 
controlled study comparing PPPD and Pylorus­resecting 
PD (PrPD), showing that PrPD was associated with a 
low incidence of DGE; however, during a 6­mo follow­
up period, comparable outcomes for quality of life, 
weight loss, and nutritional status between the two 
groups were observed.
REMNANT PANCREATIC FUNCTION
Previously, most concerns after PD were postoperative 
pancreatic fistula, because it was one of the main 
causes of significant morbidity and mortality related 
to PD. However, with advances in surgical techniques, 
Ref. Year Study design Primary end 
point
Observations
Eshuis et al[81] 2014 In PPPD
Antecolic (n = 125) vs 
Retrocolic (n = 121)
DGE No differences in DGE
(45 patients (36%) vs 41 (34%), absolute risk difference: 2.1% 
(95%CI: -9.8-14.0)
No differences in need for postoperative nutritional support, other 
complications, hospital mortality, and median length of hospital stay
Tamandl et al[82] 2014 In PPPD,
antecolic (n = 36) vs retrocolic 
(n = 28)
DGE No differences in DGE
(17.6% vs 23.1%, P = 0.628)
No differences in length of hospital stay [13.0 (10.0-17.5) vs 12.5 (11.0-17.0) 
days; P = 0.446], time to regular diet [5 (5-7) d vs 5 (4-6) d, P = 0.353], and NG 
tube requirement [4 (3-7) d vs 3 (3-5) d, P = 0.600]
Imamura et al[83] 2014 In PPPD,
antecolic (n = 58) vs vertical 
retrocolic (n = 58)
DGE No difference in DGE (12.1% vs 20.7%, P = 0.316)
At postoperative 6 mo, DGE was accelerated in antecolic group
At postoperative 12 mo, better postoperative weight recovery in vertical 
retrocolic group (93.8% ± 1.2% vs 98.5 % ± 1.3%, P = 0.015)
Tani et al[84] 2014 In PD,
Conventional (n = 76) vs 
Isolated Roux-en-Y (n = 77)
POPF/DGE No differences in DGE and POPF
POPF: conventional (34%) vs isolated Roux-en-Y (33%), P = 0.909
DGE: conventional (12%) vs isolated Roux-en-Y (15%), P = 0.609
Shimoda et al[85] 2013 In SSPPD,
Billroth Ⅱ
(n = 52) vs Roux-en-Y (n = 
49)
DGE Lower DGE in Billroth Ⅱ: 
(5.7% vs 30.4%, P = 0.028)
Shorter hospital stay in Billroth Ⅱ
(31.6 ± 15.0 d vs 41.4 ± 20.5 d, P = 0.037)
Significant association between POPF and DGE (P = 0.037)
Ke et al[86] 2013 In PD DGE/POPF No differences in DGE and POPF
Continuous loop (n = 109) vs 
Roux-en-Y (n = 107)
POPF: continuous loop (17.6%) vs Roux-en-Y (15.7%), P > 0.05
DGE: continuous loop (25%) vs Roux-en-Y (23%), P > 0.05
Gangavatiker et al[87] 2011 In conventional PD and 
PPPD
Antecolic (n = 32) vs 
Retrocolic (n = 36)
DGE No difference in DGE
(34.4% vs 27.8%, P = 0.6)
Kurahara et al[88] 2011 In SSPPD,
Antecolic (n = 24) vs 
retrocolic (n = 22)
DGE Lower incidence of DGE in the antecolic group [20.8% vs 50%, P = 0.0364, 
especially in the incidence of DGE grade B/C (4.2% vs 27.3%, P = 0.0234)]
Significantly shorter time to full resumption of diet in antecolic group
No significant difference in other postoperative complications
Chijiiwa et al[89] 2009 In PPPD,
Antecolic (n = 17) vs 
retrocolic (n = 18)
DGE No difference in DGE
DGE: 6% vs 22%, P = 0.34
PPPD: Pylorus-preserving pancreaticoduodenectomy; DGE: Delayed gastric emptying; PD: Pancreaticoduodenectomy; POPF: Postoperative pancreatic fistula.
Table 3  Definition of postoperative pancreatic fistula
Postoperative pancreatic fistula
Grade A B C
General appearance 
(clinical condition)
Well Often Well Ill appearing, Bad
Medical or 
interventional approach
No Yes or No Yes
Postoperative radiologic 
finding (US/CT)
Negative Negative or 
Positive
Positive
Long-time drainage (≥ 
21 d)
No Usually Yes Yes
Reoperation No No Yes
Mortality related to 
POPF
No No Possibly yes
Sign of infection No Yes Yes
Sepsis No No Yes
Readmission No Yes or No Yes or No
US: Ultrasonography; CT: Computed tomographic scan; POPF: 
Postoperative pancreatic fistula.
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perioperative management, and interventional 
radiology, most PD­related complications can now be 
managed by conservative methods, and surgeons 
have begun to focus on long­term functional outcomes 
after PD.
Several reports have shown a potential relationship 
between morphologic changes (pancreatic atrophy, 
stricture, and main pancreatic duct dilatation) and 
remnant pancreatic function after PD[42­46]. Notably, 
Lemaire et al[47] evaluated pancreatic function, 
pancreatic atrophy, and main pancreatic duct dilation 
in the remnant pancreas after PD. They found a 
significant reduction in pancreatic parenchymal 
thickness and increased dilation of the main pancreatic 
duct in remnant pancreas. Finally, pancreatic atrophy 
tended to develop over time, and all patients were 
reported to have reduced levels of fecal­1 elastase. 
Nakamura et al[48] also demonstrated reduced 
pancreatic parenchymal thickness (atrophy), which 
indicated pancreatic exocrine insufficiency after PD. 
Therefore, this morphological change can indirectly 
show the some aspects of exocrine function in the 
remnant pancreas remain after PD. Tomimaru et 
al[49] reported a significant atrophy of the pancreatic 
parenchyma that occurred postoperatively in the PG 
and PJ groups (p < 0.0001), but these changes were 
more severe in the PG group than in the PJ group 
(p = 0.0018), suggesting that PJ was preferable to 
PG after PD. Fang et al[50] evaluated the long­term 
morphological and functional outcomes of the remnant 
pancreas after PD. The pancreatic duct diameter in the 
remnant pancreas usually increased, but there was no 
Table 4  Recent clinical studies about fatty liver after pancreaticoduodenectomy









Song et al[90] 2011 228 16 When CTS-L was equal 
to or less than 10 HU
When CTL/S was equal 
to or less than 0.9 HU
15 (7.8) In multivariate analysis,
Pancreatic fistula (HR = 3.332, P = 0.037)
External pancreatic duct stent (HR = 4.530, P = 0.017)
Sato et al[91] 2014 110   6 Hepatic CT value of less 
than 40 HU
44 (40) In multivariate analysis,
Younger age (OR = 1.079, P = 0.002), Female (OR = 
6.102, P < 0.001)
Small remnant pancreatic volume (< 10 mL), OR = 
4.109, P = 0.009
Suspicion infection on POD7-28 (OR = 3.109, P = 0.027)
Kato et al[92] 2010   54 7.7 ± 2.1 Hepatic CT value of less 
than 40 HU a
20 (37.0) In multivariate analysis,
Pancreatic adenocarcinoma (P < 0.05)
Pancreatic resection line (left side of SMA, SMA/PV) 
(P < 0.01)
Diarrhea (P < 0.05)
Nagai et al[71] 2014 361   6 When CTL/S was equal 
to or less than 0.9 HU
30 (8.3) In patients with NAFLD, CTL/S ratio was 
significantly improved by pancrelipase treatment
Nutritional status by total protein, albumin, 
and cholesterol was significantly improved by 
pancrelipase treatment
Severe diarrhea was improved
Malnutrition after PD might be cause for 
postoperative NAFLD
Ito et al[93] 2014 100 NA When CTL/S was equal 
to or less than 0.9 HU
12 (12) In multivariate analysis,
Blood loss (HR = 1.001, P = 0.016)
Nakagawa et al[94] 2014 104 Median 7.7 
(2.5-23.6)
When CTS-L was equal 
to or less than 10 HU
26 (25) In multivariate analysis,
Postoperative pancreatic exocrine insufficiency (HR = 
4.16, P = 0.02)
Tanaka et al[72] 2011   60 12 When CTL/S was equal 
to or less than 0.9 HU
When CTL/S was equal 
to or less than 0.9 HU
14 (23) In multivariate analysis,
Pancreatic head cancer (OR = 12.0, P = 0.006)
De novo NAFLD after PD was associated with body 
weight loss and decreases in serum levels of albumin, 
cholinesterase, and total cholesterol
After administration of pancreatic enzyme, body 
weight and serum concentrations of albumin, 
cholinesterase, and total cholesterol were markedly 
increased
In addition, hepatic steatosis and serum AST and 
ALT levels were also significantly improved by 
treatment
De novo NAFLD after PD was primarily
caused by pancreatic exocrine insufficiency
NAFLD: Non-alcoholic fatty liver disease; NA: Not available; AST: Aspartate transaminase; PD: Pancreaticoduodenectomy.
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significant difference in the pancreatic duct diameter 
in both the PJ and PG groups, indicating that there 
was no significant difference in pancreatic exocrine or 
endocrine insufficiency, or pancreatic morphological 
changes. This evidence strongly suggests that the 
remnant pancreas following PD will have a chance to 
undergo atrophic changes and deteriorating exocrine 
pancreatic function after a long period of time.
Generally, there are two methods for remnant 
pancreatic reconstruction; PJ and PG. Several 
theoretical concerns exist regarding the functional 
outcome of the remnant pancreas following PD, 
which are as follows: (1) because of the absence of 
ampullary function, the remnant pancreas is thought 
to be vulnerable to regurgitation of gastrointestinal 
fluid into the main pancreatic duct. Most notably in 
PG, reflux of ingested food and low pH-gastric juice to 
the pancreatic duct can result in chronic inflammation, 
stenosis, and inactivation of pancreatic enzymes, 
leading to insufficiency of the remnant pancreas[51,52]; 
(2) in PJ, the easy activation of pancreatic enzymes 
can occur by intestinal enterokinase and an alkaline 
pH, resulting in irritating the remnant pancreas and 
clinically relevant pancreatic fistula[53]; and (3) reduced 
plasma levels of gastrin resulting from removal of 
the duodenum and distal part of stomach can affect 
atrophic changes of the remnant pancreas[15,16].
Interestingly, no significant difference in posto­
perative morbidity has been observed, even for 
postoperative pancreatic fistula[54] (POPF, Table 3), 
between PG and PJ[55­58]. However, a recent meta­
analysis[59] demonstrated that PG was associated with 
lower postoperative pancreatic and biliary fistula rates 
in PD. One RCT dataset[60] showed that PG was related 
not only to a lower POPF rate but also to lower weight 
loss and better exocrine pancreatic function compared 
with PJ, suggesting that the “battle” between PG and 
PJ is ongoing. Most available reports on the functional 
outcome of the remnant pancreas following PD were 
based on retrospective study designs and limited 
numbers of patients. Most RCTs that tested PG and PJ 
focused on short­term perioperative outcomes, such as 
morbidity and mortality. Therefore, further evidence-
based clinical investigations about remnant pancreatic 
function following PD should be performed.
NON-ALCOHOLIC FATTY LIVER DISEASE
Non­alcoholic fatty liver disease (NAFLD) is thought 
to be associated with excessive nutrition and is one of 
the most common forms of chronic liver disease[61]. 
This disease started to be reported in late 1980[62], 
and a few clinical investigations correlating fatty liver 
and PD reported that PD can influence hepatic fat 
content, which was associated with frequent hepatic 
steatosis[63,64]. In severe cases, even steatohepatitis 
leading to hepatic decompression can develop because 
of malnutrition after PD[65]. Therefore, surgeons 
need to be concerned about this condition, especially 
in patients expecting long­term survival following 
PD. Recent clinical studies of fatty liver after PD are 
summarized in Table 4.
The mechanisms underlying NAFLD after PD 
(Figure 2) might differ from usual NAFLD associated 
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with metabolic syndrome because NAFLD after PD 
was related to non­obese status, malnutrition, and a 
lack of hyperlipidemia or insulin resistance[66]. Most 
studies listed in Table 4 directly and indirectly suggest 
that malnutrition resulting from exocrine pancreatic 
insufficiency might cause NAFLD after PD. Pancreatic 
exocrine insufficiency induced malabsorption of 
essential amino acids, such as choline, which might 
result in the development of NAFLD after PD[67]. It 
has been shown that choline deficiency reduces 
plasma levels of apoprotein B[68], a major component 
very­low­density lipoprotein (VLDL), suggesting 
impaired hepatic export of TG in the form of VLDL. 
Insufficient secretion of insulin could play another 
role in the development of NAFLD after PD, which 
can enhance peripheral lipolysis and increase hepatic 
FFA uptake, and liver could have some difficulty in 
handling hepatic fat secretion by coupling triglyceride 
to apoprotein B[69], which plays an important role 
in secreting triglycerides from hepatocytes as VLDL 
particles. Overgrowth of small intestinal bacteria and 
hepatic stimulation of LPS[70] because of intestinal 
motor dysfunction and stasis can reduce the secretion 
of gastric juices and blind loops can also play an 
important role in NAFLD after PD. Therefore, NAFLD 
after PD represent the nutritional status of patients and 
is clinical reflection of the pathophysiological changes 
that occur after PD. Interestingly, NAFLD after PD is 
known to be associated with pancreatic cancer[71,72] and 
chemotherapy[73], so it will be interesting to investigate 
the potential correlation between the degree of post­
hepatic steatosis and oncologic outcomes in resected 
pancreatic head cancer.
CONCLUSION
Previously, surgical techniques and safety were the 
only concerns regarding PD. This technique was 
regarded as one of the most complex and risky surgical 
procedures. However, as a consequence of advances 
in surgical experiences, techniques, and perioperative 
management, PD has become safer and the gold 
standard for treating periampullary pathologies. PD 
accompanies the removal of important organs and 
rearrangement of flow in the upper gastrointestinal 
tract, which can result in altered normal physiology 
and distinct clinical manifestations. In addition to 
proper surgical techniques, pancreatic surgeons need 
to understand these potential pathophysiological 
changes that can occur after PD for proper patients 
care in clinical practice. Further studies to link these 
potential pathophysiological changes with clinical 
outcomes will yield new insights to better understand 
how PD affects the lives of patients.
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